KEY TAKEAWAY: According to a MyTherapy 2015 survey, 96% of pharma apps have less than 100k downloads, 50% have only been updated once or never and 48% of users leave no good reviews. Should pharma walk away from apps? No!
KEY TAKEAWAY: The whole world is going mobile but there is a huge difference between developing an app vs. executing a “mobile strategy. The best way to reach HCP’s and patients is not with an app, but rather ensuring your site is mobile friendly.
According to eMarketer: 43 US consumers switched to smartphones in the time it took you to read this. As healthcare moves to the efficiency of online communications the development of health apps is going to continue to play a bigger role in healthcare. Biopharma marketers should be developing capabilities and learnings now when it comes to mobile apps for health because the future is in mobile.
KEY TAKEAWAY: The majority of physicians are skeptical of health apps because they’re not sure if they record accurate data and if patients are using them correctly. Pharma, if they want to develop apps, has to use the same processes to convince physicians that the apps are reliable.